Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

143.55
-0.2200-0.15%
Volume:1.17M
Turnover:169.52M
Market Cap:57.31B
PE:-17.93
High:146.75
Open:145.41
Low:143.00
Close:143.77
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.85
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.48
PE(LYR):-19.77

Loading ...

Moderna Shares up 4% Premarket After US FDA Approval for Flu Vaccine

THOMSON REUTERS
·
Aug 06

Moderna Secures FDA Approval for First mRNA Flu Vaccine After Regulatory Hurdles, Commercial Prospects Remain Uncertain

Stock News
·
Aug 06

PRESS Digest -Wall Street Journal - August 6

Reuters
·
Aug 06

PRESS Digest-New York Times Business News - August 6

Reuters
·
Aug 06

US FDA Approves First mRNA Flu Shot from Moderna

Reuters
·
Aug 06

Moderna: Gets U.S. FDA Approval for Influenza Vaccine Mflusiva for Use in Adults 50 Years and Older

THOMSON REUTERS
·
Aug 06

Moderna: Expects Supply of Influenza Vaccine Mflusiva to be Available in Select Retailers in Coming Weeks

THOMSON REUTERS
·
Aug 06

Moderna Shingles Vaccine Trial Terminated: What It Means for MRNA Investors

TIPRANKS
·
Aug 06

Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Dow Jones
·
Aug 05

Moderna announces initiation of Phase 1 trial of mRNA-1469

TIPRANKS
·
Aug 04

Moderna Publishes Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 04

Moderna: Mrna-1469 Phase 1 Trial Conducted in Canada as Part of Expanded Collaboration with Coalition for Epidemic Preparedness Innovations

THOMSON REUTERS
·
Aug 04

Moderna: Under Cepi Agreement, Commits Minimum 500,000 Doses of Mrna-1469 Vaccine for Low- and Middle-Income Countries Under Access Pricing

THOMSON REUTERS
·
Aug 04

Moderna: Mrna-1469 Phase 1 Trial to Evaluate Safety & Immune Response for Bundibugyo Ebolavirus

THOMSON REUTERS
·
Aug 04

J.P. Morgan Remains a Sell on Moderna (MRNA)

TIPRANKS
·
Aug 04

Stock Track | Moderna Soars 5.53% Intraday on Analyst Upgrades and PDUFA Catalyst

Stock Track
·
Aug 04

Movement Alert|Moderna, Inc. Rises 5.28% in Regular Trading, Multiple Analyst Upgrades and PDUFA Date Catalyze Rally

Market Focus
·
Aug 04

Moderna is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

Moderna Facing Several Vaccine Headwinds in Near, Medium Term, RBC Says

MT Newswires Live
·
Aug 04

Movement Alert|Moderna, Inc. Rises 5.11% in Regular Trading, Multiple Institutions Raise Price Targets Ahead of Key PDUFA Date

Market Focus
·
Aug 03